SMMT - サミット・セラピュ―ティクス (Summit Therapeutics plc)

SMMTのニュース

   Summit Therapeutics reports data for DDS-04 for Enterobacteriaceae at ECCMID 2019  2019-04-15
Summit Therapeutics (NASDAQ: SMMT ) presents in vivo proof of concept data for the DDS-04 series of new mechanism antibiotics targeting Enterobacteriaceae atECCMID 2019 in Amsterdam. More news on: Summit Therapeutics, Healthcare stocks news, Read more …
   Summit Therapeutics Q3 revenues down 73%  2018-12-11
Summit Therapeutics ( SMMT ) Q3 results (): Revenues: 0.7M (-73.1%). More news on: Summit Therapeutics, Healthcare stocks news, Earnings news and commentary, , Read more …
   Summit Therapeutics beats by $0.02, misses on revenue  2018-12-11
Summit Therapeutics (NASDAQ: SMMT ): Q3 GAAP EPS of -$0.13 beats by $0.02 . More news on: Summit Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more …

calendar